The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Limited relevance of the “very low risk” prostate cancer classification in the modern era: Results from a large institutional active surveillance cohort.
 
Kevin Shee
No Relationships to Disclose
 
Janet E. Cowan
Stock and Other Ownership Interests - GlaxoSmithKline (I); McKesson (I)
 
Samuel L. Washington
Research Funding - ConcertAI
 
Hao G Nguyen
No Relationships to Disclose
 
Katsuto Shinohara
No Relationships to Disclose
 
Peter Carroll
Stock and Other Ownership Interests - Nutcracker Therapeutics, Inc.; Nutcracker Therapeutics, Inc.
Honoraria - BIOPHARM; Exact Sciences
Consulting or Advisory Role - Alessa Therapeutics; Francis Medical; Insightec; Nutcracker Therapeutics, Inc.; Progenics
Research Funding - Intuitive Surgical (Inst)
 
Matthew R. Cooperberg
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bayer; ConcertAI; Dendreon; Exact Sciences; Merck; Pfizer; Veracyte; Verana Health